A Classification Tool for Differentiation of Kawasaki Disease from Other Febrile Illnesses - 25/08/16
on behalf of the
Pediatric Emergency Medicine Kawasaki Disease Research Group∗
Abstract |
Objective |
To develop and validate a novel decision tree-based clinical algorithm to differentiate Kawasaki disease (KD) from other pediatric febrile illnesses that share common clinical characteristics.
Study design |
Using clinical and laboratory data from 801 subjects with acute KD (533 for development, and 268 for validation) and 479 febrile control subjects (318 for development, and 161 for validation), we developed a stepwise KD diagnostic algorithm combining our previously developed linear discriminant analysis (LDA)–based model with a newly developed tree-based algorithm.
Results |
The primary model (LDA) stratified the 1280 subjects into febrile controls (n = 276), indeterminate (n = 247), and KD (n = 757) subgroups. The subsequent model (decision trees) further classified the indeterminate group into febrile controls (n = 103) and KD (n = 58) subgroups, leaving only 29 of 801 KD (3.6%) and 57 of 479 febrile control (11.9%) subjects indeterminate. The 2-step algorithm had a sensitivity of 96.0% and a specificity of 78.5%, and correctly classified all subjects with KD who later developed coronary artery aneurysms.
Conclusion |
The addition of a decision tree step increased sensitivity and specificity in the classification of subject with KD and febrile controls over our previously described LDA model. A multicenter trial is needed to prospectively determine its utility as a point of care diagnostic test for KD.
Le texte complet de cet article est disponible en PDF.Keywords : incomplete KD, KD diagnosis, LDA, random forest, 2-step algorithm
Abbreviations : AHA, CRP, ED, KD, LAD, LDA, NPV, PPV, RCA
Plan
Supported by the American Heart Association (to H.C. and X.L.), Stanford University Spark Program (H.C. and X.L.), the David Gordon Louis Daniel Foundation (to J.B.), the Mario Batali Foundation (J.B.), the National Institutes of Health, National Heart, Lung, Blood Institute (HL69413 [to J.B.]), the Hartwell Foundation (to A.T.), and the Harold Amos Medical Faculty Development Program/Robert Wood Johnson Foundation (to A.T.). The authors declare no conflicts of interest. |
Vol 176
P. 114 - septembre 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?